PolypharmS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-12
Share capital
1 000 000,00 PLN
Activity description

Polypharm is a pharmaceutical wholesaler that offers medicinal products, medical materials, dietary supplements, and cosmetics. The company also imports pharmaceuticals from outside the EU and provides storage services for medicinal products. Additionally, it engages in parallel import of well-known brand medicines at lower prices.

Registered address
ul. Julianowska 41, 05-500 Piaseczno, Poland
Website
polypharm.plWebsite active
Email
Email warning
Phone
Electronic delivery address
AE:PL-79111-58460-GIGVH-29

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 13.66mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 898.23kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 12.40mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 8.98mMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 1996-01-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

7 public aid cases recorded, with a total value of $50,564.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$5,077
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$12,879
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$5,470

Tenders

113 tenders recorded as contractor: 82 national ($1,200,703) and 31 EU ($23,516,625).

SubjectAmount
Szczepionka przeciw wirusowemu zapaleniu wątroby typu B (WZW typu B) dla dzieci, inj. 0,5 ml. Części: 1-4; znak postępowania: ZZP.ZP.411.132.2026
—
DFP.271.127.2026.AB
—
Dostawa produktów leczniczych
$7.8M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Monika Alicja Małachowska — President of the Management Board

Manner of representation

Individual representation – member of the management board.

Supervisory board

Magdalena Izabella Bielicka — Supervisory Board Member
Tadeusz Jakubowski — Supervisory Board Member
Sławomir Tomasz Leman — Supervisory Board Member

Beneficial owners

Person
Agnieszka Małachowska (41)
Monika Małachowska (38)

Competitors

Name
Biuro Handlowe Elroy Krystyna Maria Rojek Leszek Michał Rojeksp. j.
Synkmedsp. z o.o.
Midas Pharma Polskasp. z o.o.
Livistosp. z o.o.
OwlieS.A.
Biochem PolskaS.A.
Nutropharmasp. z o.o.
Prodpolsp. z o.o.
Euroleki Gksp. z o.o. + limited partnership
Bestpharmasp. z o.o.

Change history

DateEvent
2025-07-30Address change
2003-04-15Share capital change
2001-10-12Entered in the register

FAQ

Last updated: 2026-04-02